Jul
01
2014
Recent news has custom-drug makers under public and government scrutiny. The US Food and Drug Administration has citied drug makers for not meeting new regulations passed by President Barack Obama when he enacted the federal Drug Quality and Security Act in November of 2013. This new act is designed to rein in larger drug facilities […]
Read More >